BeiGene logo

BeiGene

BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

2164 employees · est. 2010 · Cambridge, United States

VS
Novartis logo

Novartis

Reimagining medicine by transforming cancer

86998 employees · est. 1996 · Basel, Switzerland

Novartis is the older company (2010 vs 1996); Novartis is the larger of the two.

Side-by-Side Comparison

BeiGene Novartis
Founded
2010 1996 older
Headquarters
Cambridge, United States Basel, Switzerland
Employees
2164 86998 larger
Industry
Not tracked yet Biotechnology, Pharmaceutical
Funding Stage
IPO IPO
Total Funding
$6.69B $6.01B
Funding Rounds
9 3
Services
Cancer Treatment Development, Clinical Research and Trials, Patient Assistance Programs, Biopharmaceutical Manufacturing Therapeutic Area Research, Medicines Development, Health and Safety Training, Product Recalls Management, Managed Access Programs, Third-party Supplier Management
Target Customers
Cancer Patients, Healthcare Providers, Medical Researchers, Investors Patients, Healthcare Professionals, Pharmaceutical Researchers, Patient Organizations, Caregivers, Investors
Taxonomy
Life Sciences, Innovative Medicines, Cancer Treatment, Immuno-oncology, Hematology, Oncology, Targeted Therapy, Global Rebranding, Patient Partnerships, Pharmaceutical Development, Therapeutic Innovation, Global Healthcare, Redomiciliation, Shareholder Engagement Innovative Medicines, Oncology, Cancer Therapy, Drug Development, Patient Care Solutions, Molecular Pathways, Solid Tumors, Hematology, Gene And Cell Therapy, Radioligand Therapy, XRNA Technology, Cardiovascular Research, Neuroscience, Immunology
Website
beonemedicines.com novartis.com
BeiGene logo

About BeiGene

BeiGene, now rebranding as BeOne Medicines Ltd., is a notable player in the life sciences biotechnology sector. Founded in 2010, the company has been instrumental in developing innovative cancer therapies. The company recently changed the name of its U.S. subsidiary to BeOne Medicines USA, Inc. as...

Novartis logo

About Novartis

Novartis is a prominent player in the Biotechnology and Pharmaceutical industries, headquartered in Switzerland and founded in 1996. With a mission of "Reimagining medicine by transforming cancer," Novartis is dedicated to innovating and enhancing healthcare solutions on a global scale. The company...

We will tell you when either one moves

BounceWatch watches BeiGene and Novartis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BeiGene and Novartis — by email.

Frequently Asked Questions

BeiGene — BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company. Novartis — Reimagining medicine by transforming cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BeiGene has raised $6.69B while Novartis has raised $6.01B.
BeiGene and Novartis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BeiGene with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BeiGene on 11 Mar 2026, and Novartis on 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes